U.S. airport entry screening in response to pandemic influenza: Modeling and analysis

Background: A stochastic discrete event simulation model to assess the effectiveness of passenger screening for Pandemic Influenza (PI) at U.S. airport ports of entry was developed. Methods: International passengers arriving at 18 U.S. airports (AP) from Asia, Europe, South America, and Canada were...

Full description

Saved in:
Bibliographic Details
Published in:Travel medicine and infectious disease 2009-07, Vol.7 (4)
Main Authors: Malone, John D., Brigantic, Robert, Muller, George A., Gadgil, Ashok, Delp, Woody, McMahon, Benjamin H., Lee, Russell, Kulesz, Jim, Mihelic, F. Matthew
Format: Article
Language:English
Subjects:
Airport Screening
GENERAL AND MISCELLANEOUS
Pandemic Influenza
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: A stochastic discrete event simulation model to assess the effectiveness of passenger screening for Pandemic Influenza (PI) at U.S. airport ports of entry was developed. Methods: International passengers arriving at 18 U.S. airports (AP) from Asia, Europe, South America, and Canada were assigned to one of three states: not infected, infected with PI, infected with other respiratory illness. Passengers passed through layered screening then exited the model. 80% screening effectiveness was assumed for symptomatic passengers; 6% asymptomatic passengers. Results: In the first 100 days of a global pandemic, U.S. AP screening would evaluate over 17M passengers with 800K secondary screenings. 11,570 PI infected passengers (majority asymptomatic) would enter the U.S. undetected from all 18 APs. Foreign airport departure screening significantly decreased the false negative (infected/undetected) passengers. U.S. attack rates: no screening (26.9% - 30.9%); screening (26.4% - 30.6%); however AP screening results in 800K to 1.8M less U.S. PI cases; 16K-35K less deaths (2% fatality rate). Antiviral medications for travel contact prophylaxis (10 contacts/ PI passenger) was high - 8.8M. False positives all 18 APs: 100-200/day. Conclusions: Foreign shore exit screening greatly reduces numbers of infected PI passengers. U.S. AP screening identifies 50% infected individuals; efficacy is limited by the asymptomatic PI infected. Screening will not significantly delay arrival of PI via international air transport, but reduce the number of US cases and deaths.
ISSN:1477-8939
1873-0442
DOI:10.1016/j.tmaid.2009.02.006